Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel PPAR ligands jointly disclosed by Fujisawa and Daicel

Feb. 17, 2005

Pfizer claims new cannabinoid CB1 receptor antagonists for obesity

Feb. 17, 2005

Private financing will fund Jerini's icatibant development

Feb. 17, 2005

Tibolone reduces hot flushes and sweats in tamoxifen-treated breast cancer patients

Feb. 16, 2005

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Feb. 16, 2005

Darbepoetin alfa improves chemotherapy-induced anemia in patients with gastrointestinal cancers

Feb. 16, 2005

New data on the effects of rosiglitazone on lipid metabolism in type 2 diabetes

Feb. 16, 2005

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

Feb. 15, 2005

Testosterone MDTS improves sexual desire in women with HSDD

Feb. 15, 2005

Tev-Tropin launched in U.S.

Feb. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...